Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specific Use-result Surveillance of Spiriva Respimat in Asthmatics (Patients With Severe Persistent Asthma)

NCT02489981 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02489981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02489981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specific Use-result Surveillance of Spiriva Respimat in Asthmatics (Patients With Severe Persistent Asthma)
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
June 1, 2015
Completion date
September 28, 2017
Enrollment
359 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma